TNYA has 36-month beta value of 2.91. Analysts have mixed views on the stock, with 6 analysts rating it as a “buy,” 3 as “overweight,” 0 as “hold,” and 0 as “sell.”
The public float for TNYA is 127.19M, and currently, short sellers hold a 11.32% ratio of that float. The average trading volume of TNYA on March 18, 2025 was 4.46M shares.
TNYA) stock’s latest price update
Tenaya Therapeutics Inc (NASDAQ: TNYA)’s stock price has increased by 4.45 compared to its previous closing price of 0.70. However, the company has seen a 44.35% increase in its stock price over the last five trading sessions. 247wallst.com reported 2025-03-11 that Things are heating up in the biotechnology space, with a flurry of recent initial public offerings and some notable insider purchases of the past week or so.
TNYA’s Market Performance
Tenaya Therapeutics Inc (TNYA) has experienced a 44.35% rise in stock performance for the past week, with a -22.92% drop in the past month, and a -80.05% drop in the past quarter. The volatility ratio for the week is 14.91%, and the volatility levels for the past 30 days are at 15.41% for TNYA. The simple moving average for the last 20 days is -9.55% for TNYA stock, with a simple moving average of -67.82% for the last 200 days.
Analysts’ Opinion of TNYA
Leerink Partners, on the other hand, stated in their research note that they expect to see TNYA reach a price target of $7. The rating they have provided for TNYA stocks is “Outperform” according to the report published on November 30th, 2023.
H.C. Wainwright gave a rating of “Buy” to TNYA, setting the target price at $25 in the report published on June 15th of the previous year.
TNYA Trading at -30.64% from the 50-Day Moving Average
After a stumble in the market that brought TNYA to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -86.46% of loss for the given period.
Volatility was left at 15.41%, however, over the last 30 days, the volatility rate increased by 14.91%, as shares sank -39.17% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -48.95% lower at present.
During the last 5 trading sessions, TNYA rose by +44.35%, which changed the moving average for the period of 200-days by -82.37% in comparison to the 20-day moving average, which settled at $0.8071. In addition, Tenaya Therapeutics Inc saw -48.95% in overturn over a single year, with a tendency to cut further losses.
Insider Trading
Reports are indicating that there were more than several insider trading activities at TNYA starting from Higa Tomohiro, who sale 2,482 shares at the price of $0.54 back on Mar 10 ’25. After this action, Higa Tomohiro now owns 99,690 shares of Tenaya Therapeutics Inc, valued at $1,336 using the latest closing price.
Tingley Whittemore, the Chief Medical Officer of Tenaya Therapeutics Inc, sale 7,398 shares at $0.54 during a trade that took place back on Mar 10 ’25, which means that Tingley Whittemore is holding 174,793 shares at $3,983 based on the most recent closing price.
Stock Fundamentals for TNYA
The total capital return value is set at -1.12. Equity return is now at value -95.69, with -75.64 for asset returns.
Based on Tenaya Therapeutics Inc (TNYA), the company’s capital structure generated 0.13 points at debt to capital in total, while cash flow to debt ratio is standing at -6.65.
Currently, EBITDA for the company is -115.95 million with net debt to EBITDA at -0.09. The liquidity ratio also appears to be rather interesting for investors as it stands at 4.22.
Conclusion
To put it simply, Tenaya Therapeutics Inc (TNYA) has had a bad performance in recent times. Analysts have a bullish opinion on the stock, with some rating it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
